Description
Mécanisme d’action
12.1 Mecanisme d action Mecanisme d action
Pharmacologie
12.1 Mecanisme d action IPF Mecanisme d action 12.2 QT , 160 2403 mg/ 4005 mg/ 1.6 10 , 400 mg , 2403 mg/ 4005 mg/ QT 3.2 ms 2.2 ms
Precautions
5.1 (DILI) , DILI , III , 2403 mg ALT AST ≥3×ULN 3.7% 0.8% 2403 mg ,0.3% ALT AST ≥10×ULN, 0.2% ALT AST ≥3×ULN
Interactions médicamenteuses
7.1 CYP1A2 70%~80% CYP1A2 , CYP CYP2C9 2C19 2D6 2E1 CYP1A2 CYP1A2 , [ (12.3)] CYP1A2 , CYP1A2 ,
Effets indésirables
• [ Precautions(5.1)] • [ Precautions(5.2)] • [ Precautions(5.3)] • [ Precautions(5.4)] 6.1 , , 14
Conservation
USP ,1 , , “F70” 14 4 USP NDC 33342-461-58,30 , 270
